Mr. Hank Vigil is a Founder and serves as Managing Partner at Acequia Capital. He serves as Advisor at Finlync. He is an Angel Investor. He serves as Advisor & Investor at LifeQ. He is the Founder and serves as General Partner at Acequia Capital. He served as Board Member at ClassPass. He managed Microsoft's strategic acquisitions and investments as well as its relationships with not only prominent executives in software, telecommunications, media, consumer electronics, and e-commerce but also emerging leaders in Silicon Valley and beyond. Mr. Vigil was responsible for Microsoft's strategic investments in a number of technology companies (including Facebook), its acquisition of Nokia, and its strategic partnerships with Yahoo, Time Warner, Sony, Samsung, News Corp, Vodafone, Viacom, and others. From 1989 through the launch of Office 95 in 1995, he led the overall product marketing and brand management efforts for the Microsoft Desktop Applications group, with primary responsibility for Excel and the overall strategy for the development of Microsoft Office. He serves as Board Observer at Connecterra. He served as Advisor at Parllay Studio.
Past Investments
Vantia Therapeutics, Spherics, Onbone, Zipline Medical, Solx, Oxxon Therapeutics, Horizon Discovery, Clavis Pharma, Tarsa Therapeutics, GT Medical Technologies, Cara Therapeutics, SkyCell, Heptares Therapeutics, Providence Medical Technology, Vertos Medical, Serentis, Cheetah Medical, Biotheranostics, BioVex, De Novo Pharmaceuticals, Patient Connect, BioXell, Wilson Therapeutics, eXmoor Pharma, PregLem, Aegerion Pharmaceuticals, AmbioPharm, Lombard Medical plc, Momenta Pharmaceuticals, Evotec Neurosciences, VitalConnect, Avantium Technologies, Xention, Paragon 28, eZono, Beacon Endoscopic, Vascular Pathways, MDxHealth, AccuVein